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Introduction
A single type A1 spermatogonium (diploid, 2n) in rodents,
such as rats and mice, gives rise to 256 mature spermatids
(haploid, n) in the seminiferous epithelium during
spermatogenesis (for reviews, see de Kretser and Kerr, 1988;
Cheng and Mruk, 2002; Lui et al., 2003b). For this event to
happen, preleptotene and leptotene spermatocytes must
traverse the blood-testis barrier (BTB, also known as the
seminiferous epithelium barrier) at late stage VIII and early IX
of the epithelial cycle (Russell, 1977). The BTB is constituted
largely by inter-Sertoli cell tight junctions (TJ). However, cell-
cell actin-based adherens junctions (AJ, e.g. ectoplasmic
specialization, a testis-specific AJ type) and possibly cell-cell
intermediate filament-based desmosome-like junctions (for
reviews, see de Kretser and Kerr, 1988; Pelletier, 2001; Cheng
and Mruk, 2002), are also found at the BTB site. As such, these
junctions must undergo extensive restructuring during this
process of germ cell migration. Yet the mechanism(s) that
regulates BTB dynamics remains largely unknown (for a
review, see Cheng and Mruk, 2002). 
Recently completed in vitro studies have shown that Sertoli
cell TJ dynamics are regulated, at least in part, by transforming
growth factor-b 3 (TGF-b 3) (Lui et al., 2001; Lui et al., 2003a)
and tumor necrosis factor-a (TNF-a) (Siu et al., 2003a) via the
TGF-b 3/MEKKs/p38 mitogen activated protein (MAP) kinase
and the TNF- a/ integrin-linked kinase (ILK)/p130 Crk-
associated substrate (Cas)/MAP kinase signaling pathways,
respectively. More importantly, a preliminary in vivo study has
shown that the event of BTB disruption induced by cadmium
chloride (CdCl2) indeed was mediated via the TGF-
b 3/MEKKs/p38 MAP kinase pathway (Lui et al., 2003d). Yet
it remains to be determined whether proteases, protease
inhibitors, AJ integral membrane proteins and their associated
peripheral adaptors, and signaling molecules are also involved
in TJ restructuring and, in particular, the subsequent germ cell
loss from the epithelium as a result of BTB damage. In brief,
in this study we sought to investigate whether a primary loss
of the BTB function can lead to a secondary disruption of the
AJs. We also investigated the roles of proteases and protease
inhibitors in this event, since recent in vitro studies have shown
that AJ dynamics in the testis are regulated by the intricate
interactions between proteases and protease inhibitors under
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An in vivo model was used to investigate the regulation of
tight junction (TJ) dynamics in the testis when adult rats
were treated with CdCl2. It was shown that the CdCl2-
induced disruption of the blood-testis barrier (BTB)
associated with a transient induction in testicular TGF- bb 2
and TGF- bb 3 (but not TGF- bb 1) and the phosphorylated p38
mitogen activated protein (MAP) kinase, concomitant with
a loss of occludin and zonula occludens-1 (ZO-1) from the
BTB site in the seminiferous epithelium. These results
suggest that BTB dynamics in vivo are regulated by TGF-
bb 2/- bb 3 via the p38 MAP kinase pathway. Indeed, SB202190,
a specific p38 MAP kinase inhibitor, blocked the CdCl2-
induced occludin and ZO-1 loss from the BTB. This result
clearly illustrates that CdCl2 mediates its BTB disruptive
effects via the TGF- bb 3/p38 MAP kinase signaling pathway.
Besides, this CdCl2-induced occludin and ZO-1 loss from
the BTB also associated with a significant loss of the
cadherin/catenin and the nectin/afadin protein complexes
at the site of cell-cell actin-based adherens junctions (AJs).
An induction of aa 2-macroglobulin (a non-specific protease
inhibitor) was also observed during BTB damage and when
the seminiferous epithelium was being depleted of germ
cells. These data illustrate that a primary disruption of the
BTB can lead to a secondary loss of cell adhesion function
at the site of AJs, concomitant with an induction in protease
inhibitor, which apparently is used to protect the
epithelium from unwanted proteolysis. aa 2-Macroglobulin
was also shown to associate physically with TGF- bb 3, afadin
and nectin 3, but not occludin, E-cadherin or N-cadherin,
indicating its possible role in junction restructuring in vivo.
Additionally, the use of SB202190 to block the TGF- bb 3/
p-38 MAP kinase pathway also prevented the CdCl2-
induced loss of cadherin/catenin and nectin/afadin protein
complexes from the AJ sites, yet it had no apparent effect
on aa 2-macroglobulin. These results demonstrate for the
first time that the TGF- bb 3/p38 MAP kinase signaling
pathway is being used to regulate both TJ and AJ dynamics
in the testis, mediated by the effects of TGF- bb 3 on TJ- and
AJ-integral membrane proteins and adaptors, but not
protease inhibitors. 
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the influence of cytokines (Mruk et al., 1997; Mruk et al.,
2003). Furthermore, we have examined whether TGF- b 3 can
also utilize the p38 MAP kinase pathway to regulate AJ
dynamics. These results are physiologically and clinically
important in understanding the regulation and functional
relationships of TJ and AJ dynamics. 
Materials and Methods
Animals
Male Sprague-Dawley rats (outbred) weighing 250-340 g were
purchased from Charles River Laboratories (Kingston, NY). The use of
animals in this study was approved by the Rockefeller University Animal
Care and Use Committee (Protocol Numbers 00111 and 03017).
Disruption of the BTB by CdCl2
CdCl2 was prepared as a 0.1% solution (wt/vol in Milli Q water), and
was administered to groups of rats (n=3-5 rats per time point) by
intraperitoneal injection (i.p.) at 3 mg/kg body weight (b.w.) to induce
BTB damage as previously described (Hew et al., 1993b; Setchell and
Waites, 1970; Grima and Cheng, 2000). Thereafter, rats were killed
by CO2 asphyxiation at 1, 3, 5, 7, 12, 16, 20, 24, 48, and 96 hours
after CdCl2 treatment, testes were removed from the scrotum, and the
weight of each testis was recorded (Table 1). Testes were immediately
frozen in liquid nitrogen and stored at –80°C until used. Preliminary
experiments were also conducted using 1 mg/kg b.w. of CdCl2 with
n=4 rats per time point. In most of the animals, however, the BTB
damage was not obvious at the above time points when examined by
immunohistochemistry and/or immunofluorescence microscopy using
occludin and ZO-1 as markers. Only 1 of 4 rats in the 48-hour group
and 2 of 4 rats in the 72-hour group had visible signs of BTB damage.
Consequently, a higher dose (3 mg/kg b.w.) of CdCl2 was used instead
in three subsequent experiments since all animals (n=3-5 rats per time
point) responded uniformly at this dosing when the seminiferous
epithelial barrier was examined by electron microscopy,
immunohistochemistry, and immunofluorescence microscopy.
However, it is of important to note that the changes detected in
selected target proteins, such as a 2-macroglobulin and occludin, in
rats receiving the lower concentration (1 mg/kg b.w.) of CdCl2 were
similar to those receiving 3 mg/kg b.w. CdCl2 (see Results and Fig.
2). More important, such changes in protein expressions were detected
in all animals receiving 1 mg/kg b.w. CdCl2, similar to the 3 mg/kg
b.w. treatment group. This suggests that changes in these target
proteins indeed occurred long before any physical damage to the BTB
was visible. Using 3 mg/kg b.w. of CdCl2 vascular damage in the testis
was visible by ~24 hours, since testes recovered from rats at this time
point and thereafter were reddish in color, apparently loaded with red
blood cells. Routine histological analysis indeed identified red blood
cells in the interstitium, a clear indication of vascular barrier damage
which permitted the leakage of blood cells via the opened (i.e.
disrupted) endothelial tight junctions. However, it is important to note
that physical damage to the BTB was detected as early as ~7-12 hours
by immunohistochemistry and immunofluorescence microscopy (see
Figs 3 and 4), prior to the disruption of the vascular barrier. This is
consistent with an earlier report (Setchell and Waites, 1970) that the
BTB was compromised by CdCl2 prior to vascular damage. These
preliminary results are also consistent with another report (Hew et al.,
1993b) that when CdCl2 was applied at doses of 1.5 mg/kg b.w. and
above, the testes of most rats displayed damaged vascular and
seminiferous epithelial barriers. 
Treatment of rats with MAP kinase inhibitor
To examine the effect of SB202190 [4-(4-fluorophenyl)-2-(4-
hydroxyphenyl)-5-(4-pyridyl)1H-imidazole, Calbiochem, San Diego,
CA], a specific p38 MAP kinase inhibitor (Ravanti et al., 1999), on
the CdCl2-induced TJ and AJ damages, one of the testes from each
rat (n=3-4 rats) was injected intratesticularly with SB202190 (5 m M,
assuming the testicular volume of ~1.6 ml/testis, ~8 nmol SB202190
was used per testis) prior to CdCl2 treatment (3 mg/kg b.w. via i.p.)
as described (Lui et al., 2003d). SB202190 was prepared in DMSO
(~1 mg/ml) and diluted in saline as described (Lui et al., 2003d). The
other testis of the same rat received ~200 m l of 1% DMSO in saline
(vol/vol) (vehicle control). 
Electron microscopy
Electron microscopy was used to examine the effects of CdCl2 on the
integrity of the BTB in the testis following CdCl2 treatment (3 mg/kg
b.w., i.p.). In brief, rats were treated with CdCl2 (3 mg/kg b.w., i.p.)
and killed as described above. Rats without CdCl2 treatment were
used as controls. Capsules of testes were incised to release the
seminiferous tubules. Tubules were fixed in 2.5% glutaraldehyde/
0.1 M sodium cacodylate (pH 7.4, 22°C) for 2-4 hours at room
temperature. Thereafter, tubules were post-fixed in 1% OsO4 solution
for 1 hour on ice, and stained in 1% uranyl acetate for 1 hour at
room temperature. Tubules were then dehydrated in ascending
concentrations of ethanol as follows: 70% ethanol for 30 minutes,
95% for 10 minutes and 100% for 1 hour. After dehydration, tubules
were incubated in propylene oxide for 45 minutes, and infiltrated with
EMbed (Electron Microscopy Sciences, Fort Washington, PA). After
overnight infiltration, used EMbed was discarded and replaced with
fresh EMbed, and the whole specimen was then incubated at 60°C for
2 days. Ultra-thin (~80 nm) sections were prepared on a Reichert-Jung
Ultracut E microtome and post-stained with uranyl acetate/lead.
Sections were examined and photographed on a JEOL 100CXII
electron microscope at 80 kV. Electron microscopy was performed at
the Rockefeller University Bio-Imaging Resource Center. 
Immunoblot analysis
For immunoblotting, testis lysates were prepared as follows. Briefly,
0.1 g of testis from a rat at each specified time point was suspended
in 1 ml lysis buffer A [0.125 M Tris, pH 6.8, at 22°C containing
1% SDS (wt/vol), 2 mM EDTA, 2 mM N-ethylmaleimide, 2 mM
phenylmethylsulfonylfluoride (PMSF), 1.6% 2-mercaptoethanol
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Table 1. Number of animals used and their average
testicular weights (per testis) following treatment of adult
rats (~280-290 g b.w.) with 3 mg/kg b.w. of CdCl2
No. of 
Time after CdCl2 animals Testicular weight (g) 
treatment (hours) used (mean – s.d.)
0 (Ctrl) 4 1.49±0.09
1 3 1.55±0.09ns
3 3 1.52±0.09ns
5 3 1.55±0.09ns
7 3 1.61±0.10ns
12 4 1.59±0.18ns
16 5 1.65±0.18ns
20 4 1.66±0.19ns
24 5 1.65±0.14ns
48 3 1.44±0.04ns
96 3 1.00±0.05**
*Only data of a representative experiment is shown. Another two sets of
experiments with n=3-5 rats per time point also yielded similar results, but,
these data were not pooled because the animal body weight ranges in these
other two experiments were ~250-270 g and 320-340 g, respectively and
different from this set.
ns, not significantly different from control rats at time 0 by Student’s t-test;
**Significantly different from control rats at time 0, P<0.05.
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(vol/vol), 1 mM sodium orthovanadate, and 0.1 m M sodium okadate]
in siliconized microfuge tubes. All samples within a treatment group
were processed simultaneously to eliminate inter-experimental
variations. Samples were sonicated twice, 10 seconds each with a 30-
second interval, while being incubated on ice. The clear supernatant
was collected (15,000 g, 4°C for 10 minutes) and used as testis lysate.
Protein concentration was determined by Coomassie Blue dye-
binding assay using BSA as a standard (Bradford, 1976). Equal
amounts of proteins from testis lysates (~50 m g per lane) of an
experiment were resolved by SDS-PAGE under reducing conditions.
Proteins were electroblotted onto nitrocellulose membranes and
immunostained with commercially obtained primary antibodies
[except for rabbit anti-rat cathepsin L (Lee et al., 1986) and rabbit
anti-rat a 2-macroglobulin (Cheng et al., 1990), which were prepared
against purified protein isolated from Sertoli cell-enriched culture
media, and previously characterized in our laboratory]. All primary
antibodies were known to cross-react with the corresponding target
proteins in rats according to the manufacturers (Table 2). Depending
on the origin of the primary antibody, one of the following secondary
antibodies conjugated to horseradish peroxide (HRP) was used:
bovine anti-rabbit IgG (Cat sc-2370), bovine anti-goat IgG (Cat sc-
2350) and goat anti-mouse IgG (Cat sc-2005) were purchased from
Santa Cruz Biotechnology. Target proteins on nitrocellulose
membranes were visualized by an enhanced chemiluminescence
system (Amersham Pharmacia Biotech, Piscataway, NJ) as described
(Lui et al., 2003d). The same blot was incubated in a stripping buffer
[2% (wt/vol) SDS and 100 mM 2-mercaptoethanol in 62.5 mM Tris,
pH 6.7, 22°C] at 50°C to remove the initial primary and secondary
antibodies so that at least three target proteins could be visualized in
the same blot without noticeable loss of a target protein as described
(Siu et al., 2003a). By this method, target proteins within the same
category, such as different proteases, can be compared. Each
immunoblotting experiment was repeated at least three times using
different sets of sample from different testes.
Immunohistochemistry
Streptavidin-biotin peroxidase immunostaining was carried out as
described previously (Siu et al., 2003a; Siu et al., 2003b) using
Histostain-SPTM kits (Zymed Laboratories). Cryosections of testes
embedded in OCT compound (Miles Scientific, Elkhart, IN) (~8 m m
thick) were obtained using a microtome in a cryostat (Hacker,
Fairfield, NJ) at –20°C. Frozen sections were mounted on poly-L-
lysine (molecular mass >150 kDa)-coated slides and air-dried at room
temperature, fixed in modified Bouin’s solution [4% (vol/vol)
formaldehyde in picric acid] for 5 minutes, followed by treatment with
3% (vol/vol) H2O2 in methanol for 20 minutes to block the
endogenous peroxidase activity. Thereafter, sections were incubated
with 10% non-immune goat serum to block the nonspecific binding
sites, and were subsequently incubated with primary antibodies in a
moist chamber at 4°C overnight. Primary antibodies were used at
the following dilutions: rabbit anti-ZO-1 (1:150), rabbit anti- a 2-
macroglobulin (a 2-MG; 1:350), rabbit anti-occludin (1:100) and
rabbit anti-N-cadherin (1:150). Afterwards, sections were incubated
with biotinylated goat anti-rabbit antibody for 30 minutes followed by
streptavidin-peroxidase for 10 minutes. Aminoethylcarbazole (AEC)
mixture was applied to sections as substrate for 5-10 minutes to permit
color development, which appeared as reddish-brown precipitates.
Sections were washed, counterstained with Hematoxylin, mounted in
GVA mount (Zymed Laboratories), and examined and photographed
using an Olympus BX-40 microscope (Olympus Corp., Melville, NY)
equipped with an Olympus QImaging Micropublisher cooled digital
camera (Olympus Corp.). All images were acquired and analyzed with
Adobe Photoshop (Version 7.0). Controls include sections incubated
with: (i) normal rabbit serum or preimmune serum instead of the
primary antibodies, (ii) PBS in place of the primary antibodies, and
(iii) normal rabbit serum in place of biotinylated secondary antibody. 
Immunofluorescence microscopy
Co-localization of occludin and ZO-1 to the same site in the
BTB of the rat seminiferous epithelium was performed by
immunofluorescence microscopy as earlier described (Lee et al.,
2003; Mruk et al., 2003). In brief, frozen sections of testes (~8 m m)
from normal rats and those treated with CdCl2 (3 mg/kg b.w., i.p.) 7,
12 or 24 hours earlier were mounted on poly-L-lysine-coated slides,
air dried at room temperature, and fixed in modified Bouin’s fixative.
After blocking the non-specific binding sites in testis sections using
Table 2. Sources of primary antibodies used for immunoblotting experiments
Antibody Vendor Catalog no. Lot no. Dilution used
Rabbit anti-TGF-b 3 Santa Cruz Biotechnology (Santa Cruz, CA) sc-82 A222 1:500
Rabbit anti-TGF-b 2 Santa Cruz Biotechnology sc-90 B0603 1:500
Rabbit anti-TGF-b 1 Santa Cruz Biotechnology sc-146 D0203 1:500
Rabbit anti-p38-MAPK Cell Signaling Technology (Beverly, MA) 9212 3 1:1000
Rabbit anti-p-p38-MAPK Cell Signaling Technology 9211S 3 1:1000
Rabbit anti-ERK 1/2 Cell Signaling Technology 9102 3 1:1000
Rabbit anti-occludin Zymed Laboratories (San Francisco, CA) 71-1500 11067632 1:250
Rabbit anti-ZO-1 Zymed Laboratories 61-7300 30175033 1:250
Mouse anti-E-cadherin BD Transduction Laboratories (San Jose, CA) 610182 9 1:2500
Rabbit anti-N-cadherin Santa Cruz Biotechnology sc-7939 F061 1:500
Goat anti-nectin-3 Santa Cruz Biotechnology sc-14806 K261 1:500
Rabbit anti-b -catenin Santa Cruz Biotechnology sc-7199 D171 1:500
Rabbit anti-g -catenin Santa Cruz Biotechnology sc-7900 J139 1:500
Rabbit anti-l-afadin Sigma A0349 012K4875 1:2000
Rabbit anti-p120ctn Santa Cruz Biotechnology sc-1101 K080 1:500
Mouse anti-c-Src Santa Cruz Biotechnology sc-8056 C051 1:500
Goat anti-actin Santa Cruz Biotechnology sc-1616 E0503 1:200
Mouse anti-vimentin Santa Cruz Biotechnology sc-6260 B252 1:500
Mouse anti-a -tubulin Santa Cruz Biotechnology sc-8035 G182 1:500
Rabbit anti-MMP2 Chemicon International (Temecula, CA) AB809 21082339 1:1000
Rabbit anti-MMP3 Chemicon International AB811 21100782 1:1000
Rabbit anti-uPA American Diagnostica (Greenwich, CT) 1190 010906 1:100
Rabbit anti-cathepsin L (Lee et al., 1986) 1:500
Rabbit anti-cystatin C Upstate Biotechnology (Lake Placid, NY) 06-458 21767 1:500
Rabbit anti-a 2MG (Cheng et al., 1990) 1:750
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10% normal goat serum, sections were incubated with a rabbit
polyclonal anti-occludin antibody (35°C overnight at 1:100 dilution),
to be followed by a goat-anti rabbit IgG-Cy-3 and mouse monoclonal
anti-ZO-1 IgG-FITC (Cat. 33-9100, Lot 20269234, Zymed) (35°C
overnight at 1:100 dilution). Sections were then washed, mounted in
Vectashield, and fluorescence microscopy was performed using an
Olympus BX40 microscope equipped with Olympus UplanF1
fluorescence optics. All images were digitally acquired using an
Olympus Q-Color 3 cooled digital camera and analyzed with Adobe
Photoshop (Version 7.0) in a Macintosh G4 workstation.
Immunoprecipitation
Testis lysates for immunoprecipitation were prepared as described
above but in lysis buffer B [10 mM Tris, pH 7.4 at 22°C, containing
1% (vol/vol) NP-40, 0.15 M NaCl, 2 mM PMSF, 2 mM EDTA, 2 mM
N-ethylmaleimide, 1 mM sodium orthovanadate, 0.1 m M sodium
okadate, and 10% (vol/vol) glycerol]. Equal amounts of proteins
(~400 m g) from testis lysates were pre-incubated with 1% (vol/vol)
normal rabbit serum for 3 hours, to be followed by another 3-hour
incubation with 10 m l protein A/G PLUS-agarose (Santa Cruz
Biotechnology), and samples were then centrifuged at 1000 g for 5
minutes. This step is important to eliminate non-specific interactions
of serum proteins in the following step. Thereafter, supernatant was
collected and incubated with 0.5 m l anti-a 2MG antibody or 2 m g of
anti-TGF- b 3 at 4°C overnight, with agitation using a rotator (Glas-
Col, Terre Maute, IN) at ~24 cycles/minute. 20 m l of a protein A/G
PLUS-agarose suspension was then added to precipitate the
immunocomplexes. Immunoprecipitates were washed four times with
lysis buffer B by resuspension and centrifugation (1000 g, for 5
minutes). 50 m l of SDS sample buffer [0.125 M Tris, pH 6.8 at 22°C,
containing 1% SDS (wt/vol), 1.6% 2-mercaptoethanol (vol/vol)
and 20% glycerol (vol/vol)] was then added, followed by heating at
100°C, for 10 minutes to extract and denature protein from the
immunocomplexes. Protein A/G PLUS-agarose was removed by
centrifugation (1000 g, for 5 minutes), and supernatant was resolved
by SDS-PAGE. Proteins were electroblotted onto nitrocellulose
membranes and blots were probed with different antibodies. All
antibodies used for immunoblotting described herein are the same as
described above, except that anti-TGF-b 3 is a monoclonal antibody
(Cat MAB643, Lot BHT04) from R&D Systems (Minneapolis, MN).
Testis lysates obtained from rats at 20 hours after CdCl2 treatment
were used as positive controls to verify if a primary antibody indeed
reacted with its target protein. Testes lysates without any incubation
with antibodies or incubating only with normal rabbit serum or rabbit
IgG during the immunoprecipitation step served as negative controls. 
Statistical analysis
Statistical analyses were performed by analysis of variance (ANOVA)
with Tukey’s honestly significant difference (HSD) tests or Student’s
t-tests using the GB-STAT Statistical Analysis Software Package
(version 7.0; Dynamic Microsystems, Silver Spring, MD).
Results
Ultrastructural change in the BTB after CdCl2 treatment
In normal rat testes (controls, Fig. 1A), TJs that constitute the
BTB (arrowheads) between two apposing Sertoli cells were
readily identified. Yet TJs at the site of the BTB between two
Sertoli cells became damaged and opened after treatment of
rats with 3 mg/kg b.w. CdCl2 24 hours earlier (Fig. 1B). This
pattern is somewhat similar to TJs found in rat testes at ~14
days of age, before the BTB was formed (Byers et al., 1993).
This result also illustrates that a disruption of the BTB in the
seminiferous epithelium is one of the major phenotypic
changes in the testis following CdCl2 treatment in vivo. 
Changes in the endogenous levels of different target
proteins
Changes in TGF-b s, the downstream signaling
molecules and TJ-associated proteins
Previous studies have reported that cytokines, such as TGF- b 3
and TNF-a , play a crucial role in regulating Sertoli cell-TJ
dynamics both in vitro (Lui et al., 2001; Lui et al., 2003a; Siu
et al., 2003a) and in vivo (Lui et al., 2003d). Consistent with
results of these earlier studies, the CdCl2-induced BTB damage
also led to an approximate fourfold induction of TGF- b 3 and
-b 2 between 16 and 24 hours (Fig. 2A,C), but not TGF-b 1,
suggesting that both TGF- b 2 and - b 3 are involved in BTB
dynamics. While the level of p38 MAP kinase remained
relatively stable, an induction in p-p38 MAP kinase (the
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Fig. 1. Ultrastructural analysis
of the integrity of the blood-
testis barrier (BTB) following
treatment of rats with CdCl2
(3 mg/kg b.w. via i.p.).
(A,B) Electron micrographs of
(A) the BTB between two
adjacent Sertoli cells at the
seminiferous epithelium of a
control rat, as an example of a
tight junction (TJ), which
appears as electron dense
material (arrowhead).
Magnification, · 67,500; (B) a
rat testis 24 hours after CdCl2
treatment illustrating that the
TJ were disrupted
(arrowheads). Magnification,
· 45,000. LD, lipid droplet; SC,
Sertoli cell; BM, basement
membrane; C, collagen
network; MC, myoid cell layer. 
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activated phosphorylated form of p38) (Fig. 2A,D), but not
ERK 1/2 (Fig. 2A,E) or JNK 1/2 (data not shown), was
detected. In contrast, the endogenous levels of occludin (a TJ-
integral membrane protein) and ZO-1 (a TJ peripheral adaptor
protein) remained steady in the testes until they began to
decline by about 16 hours post-treatment and were virtually
undetectable by 24 hours and thereafter (Fig. 2A,F). Such
reciprocal relationship of TGF-b 2/-b 3 and occludin in
response to BTB damage is consistent with earlier reports that
a transient reduction in TGF- b 3 was associated with an
induction of occludin and ZO-1 during Sertoli cell TJ-barrier
assembly in vitro (Lui et al., 2001; Lui et al., 2003a). 
Changes in AJ-associated proteins
When the levels of the two principal ES structural protein
complexes, namely cadherin/catenin and nectin/afadin in the
testes were examined during CdCl2-induced BTB damage, the
pattern of their expressions was similar to the two TJ proteins
(Fig. 2A,G-I). The endogenous levels of all the cadherins and
catenins examined were reduced during the CdCl2-induced
BTB disruption, although N-cadherin and b -catenin levels
began to drop earlier (~16 hours and 7 hours, respectively) than
did E-cadherin (~20 hours) and g -catenin (~48 hours) (Fig.
2A,G,H). Nectin-3 and l-afadin showed a similar pattern of
reduction as the cadherins and catenins, which started to
tumble by 20 hours and 16 hours post-treatment, respectively
(Fig. 2A,I). Two other AJ signaling molecules, p120ctn and its
upstream activator c-Src, were transiently induced in contrast
to the AJ structural protein complexes. A surge of p120ctn
protein (~3-fold) in the testis was observed between 12 and
24 hours post-treatment, and c-Src production was also
significantly induced (~2-fold) between 7 and 16 hours (Fig.
2A,J). 
Changes in cytoskeletal proteins
Besides the TJ- and AJ-associated proteins, the cytoskeletal
structural proteins were also affected during the CdCl2-induced
BTB damage (Fig. 2A,K). The expression of actin remained
stable until 24 hours after CdCl2 administration, but was
reduced by as much as 50% of the control value by 48-96 hours
(Fig. 2A,K). This result is consistent with an earlier report
illustrating that CdCl2 exposure can induce fragmentation of
actin microfilament bundles in rat seminiferous epithelium
(Hew et al., 1993b). The protein levels of vimentin, a structural
component of the intermediate filament network, and a -
tubulin, a structural protein of the microtubule network, were
also found to drop significantly, beginning at 16 hours and 48
hours, respectively (Fig. 2A,K).
Changes in proteases and protease inhibitors 
Since there are several studies indicating the crucial roles of
proteases and protease inhibitors in TJ and AJ dynamics (Mruk
et al., 1997; Mruk et al., 2003; Okanlawon and Dym, 1996;
Siu et al., 2003a; Siu and Cheng, 2004), we sought to
investigate their protein levels in the testis during CdCl2-
induced TJ and AJ restructuring (Fig. 2A,L-N). For MMP-2,
a member of the metalloproteinase family and a known
product of Sertoli cells in the testis (Longin et al., 2001), the
expression of its pro-form was apparently induced mildly by
5 hours post-treatment and persisted until 12-16 hours before
returning to its basal level (Fig. 2A,L). The levels of MMP-3,
another MMP member, and uPA, a serine protease, both of
which are also products of Sertoli cells (Longin and Le
Magueresse-Battistoni, 2002; Vihko et al., 1988) were reduced
by 20 hours post-treatment (Fig. 2A,L,M). In contrast,
cathepsin L, a Sertoli cell cysteine protease (Chung et al.,
1998; Erickson-Lawrence et al., 1991), was significantly
induced by ~3-fold beginning at 16 hours (Fig. 2A,M). One of
its specific inhibitors, cystatin C, also displayed a similar trend
of increase, except that its expression dropped significantly at
96 hours post-treatment (Fig. 2A,N) while the protein level of
cathepsin L remained high in the testis (Fig. 2A,M). The level
of another Sertoli cell secreted non-specific protease inhibitor,
a 2-MG (Cheng et al., 1990), was also induced by as much as
4-fold starting at 12 hours, and remained high until 96 hours
(Fig. 2A and N). It is of interest to note that some of these
patterns of changes in target proteins in testes were also
detected when a lower dose of CdCl2 (1 mg/kg b.w.) was used.
An induction of a 2-MG was detected by 24 hours post CdCl2
treatment, which persisted until 96 hours (Fig. 2B). This
pattern of changes, while somewhat delayed, is consistent with
results using the higher dose of CdCl2, 3 mg/kg b.w., shown
in Fig. 2A. Also, the testicular protein level of occludin was
also significantly reduced at 24 hours post CdCl2-treatment
(results not shown), consistent with results shown in Fig. 2A.
However, we opted to use 3 mg/kg b.w. CdCl2 instead of 1
mg/kg b.w. because visible damage to the seminiferous
epithelial barrier was detected by immunohistochemistry and
immunofluorescence microscopy in all animals in all three
experiments (n=3-5 rats per time point) beginning at ~7 hours
(see following and Figs. 3 and 4). Moreover, changes in
testicular weight were not detected using 3 mg/kg b.w. of
CdCl2 until 96 hours post-treatment (Table 1).
Immunohistochemical localization of ZO-1 in the
seminiferous epithelium after CdCl2 treatment
The localization of ZO-1, a TJ peripheral adaptor found at the
site of the BTB (Byers et al., 1991), in the seminiferous
epithelium was examined to assess its changes during the
CdCl2-induced BTB damage. Immunoreactive ZO-1 appeared
as reddish-brown precipitates at the basal compartment of
normal rat seminiferous tubules consistent with its localization
at the site of the BTB (Fig. 3A,C; see arrowheads in Fig. 3A).
Non-specific staining was only detected in the blood vessels
in the interstitium of the control sections (Fig. 3B), illustrating
that the staining shown in Fig. 3A,C-H is specific to ZO-1.
Control sections using PBS in place of the primary antibodies,
and normal rabbit serum instead of biotinylated secondary
antibody, also yielded no detectable staining (data not shown).
Immunoreactive ZO-1 precipitates formed an almost
continuous belt at the base of the each tubule in virtually every
stages of the epithelial cycle (see white arrowheads, Fig. 3A).
Weak staining was also found around early elongating
spermatids, consistent with an earlier report (Byers et al.,
1991). This immunostaining pattern of ZO-1 in the
seminiferous epithelium persisted until 7 hours after the CdCl2
treatment (Fig. 3D). Thereafter, the intensity of ZO-1 staining
declined and became a discontinuous ring by 12 hours post-
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treatment (Fig. 3E). By 20 hours, immunoreactive ZO-1 at the
base of the tubules became very weak (Fig. 3F), and the
staining was virtually undetectable at 24 hours and 96 hours
(Fig. 3G,H). The population of germ cells in the seminiferous
tubules also declined significantly by 24 hours, suggesting a
loss of cell adhesion function at the site of Sertoli-germ cell
interface. By 96 hours, virtually all tubules were devoid of
germ cells, confirming that a primary loss of BTB function
can lead to a secondary loss of Sertoli-germ cell adhesion
function. 
Co-localization of occludin and ZO-1 in the seminiferous
epithelium during CdCl2-induced BTB damage to assess
BTB integrity by immunofluorescence microscopy
Occludin and ZO-1 are two important interacting proteins that
co-exist in TJ fibrils in a stoichiometric ratio of 1:1 (Furuse et al.,
1994). Herein, we demonstrate that the losses of occludin and
ZO-1 during CdCl2-induced BTB damage are indeed in concert
with each other, as revealed by immunofluorescence microscopy.
Merged images showed that occludin and ZO-1 co-localized at
the basal compartment of the seminiferous tubules in both normal
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Fig. 2. Changes in cytokine levels,
different TJ- and AJ-associated
molecules, cytoskeleton
components, proteases and protease
inhibitors in rat testes during CdCl2-
induced BTB damage. (A) Rats that
had been treated with CdCl2 [3
mg/kg body weight by intra-
peritoneal injection (b.w., i.p.)] were
sacrificed and testis lysates were
prepared as described in Materials
and Methods. Proteins (~100 m g per
lane) from these lysates were
resolved by SDS-PAGE and
subjected to immunoblot analysis
using the corresponding primary
antibody as indicated.
(B) Immunoblot analysis to quantify
the levels of a 2-MG of testis lysates
from rats receiving 1 mg/kg b.w.
CdCl2. (C-N) Densitometry scans of
immunoblots, such as those shown
in A. The protein level of a
corresponding target protein at time
0 was arbitrarily set at 1. Each bar is
mean – s.d. of three to five
determinations from three to five rats
of each experiment. Two other sets
of experiments yielded virtually
identical results. nd, non-detectable;
ns, not significantly different by
ANOVA where a given sample was
compared to all other samples within
an experimental group;
*significantly different, P<0.05;
**significantly different, P<0.01.
789Regulation of BTB dynamics
(Fig. 4C compare with 4A,B) and CdCl2-treated (Fig. 4F,I,L,O
compare with D,E; G,H; J,K and M,N, respectively) rat testes. In
normal testis, occludin and ZO-1 formed continuous belts of
fluorescent staining near the basement membrane at the basal
compartment of the seminiferous epithelium, consistent with
their localization at the BTB. As the time after CdCl2 treatment
lengthened, the immunofluorescent staining of both proteins and
their merged signals gradually weakened. By 24 hours, although
some patches of weak staining were still visible in some tubules
(Fig. 4J-L), staining of both proteins became hardly detectable in
almost 90% of the tubules examined (Fig. 4M-O). These results
also illustrate the use of immunofluorescence microscopy as a
novel technique to monitor BTB integrity.
Immunohistochemical localization of a 2-MG in the
seminiferous epithelium after CdCl2 treatment
The pattern of localization of immunoreactive a 2-MG in the
seminiferous epithelium of normal rat testes, as shown in Fig.
5A, is consistent with an earlier report (Zhu et al., 1994). The
middle and right panels of Fig. 5A are the magnified views of
the left panel that show the cellular association of a 2-MG in
the seminiferous epithelium. a 2-MG was confined largely to
the perinuclear region of Sertoli cells and around the heads of
elongating and elongated spermatids at the site of apical ES in
stages XI-VII, except at spermiation, as well as in the
interstitium associated with blood vessels and possibly Leydig
cells (Fig. 5A). Very intensive a 2-MG staining was observed
at the basal compartment as well as around the head of
spermatids at the site of ES during CdCl2-induced BTB
damage (Fig. 5B, see also micrographs of higher
magnifications in the middle and right panels), which persisted
until 96 hours (Fig. 5C,D), although became weaken after 20
hours (Fig. 5C,D compare with Fig. 5B). The specificity of the
a 2-MG staining shown in Fig. 5A-D was confirmed when
control sections were incubated with pre-immune rabbit serum,
since the reddish-brown precipitates were barely detectable in
control sections (Fig. 5E). 
a 2-MG structurally associates with the actin-based
nectin/afadin ES structural protein complex, but not
cadherins, catenin, p120ctn and occludin
In order to further investigate the role of a 2-MG in the TJ/AJ
dynamics in the testis, an immunoprecipitation study was
performed using an anti-a 2-MG antibody and lysates of testes
from rats with or without CdCl2 treatment. a 2-MG was found to
structurally link to nectin-3 and l-afadin in normal testis and in
the testis 24 hours post CdCl2 treatment but not to the cadherin/
catenin/p120ctn complex (Fig. 6). It was also structurally linked
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to two major cytoskeletal proteins actin and vimentin (Fig. 6).
However, a 2-MG did not associate with occludin. There was no
structural association between a 2-MG and cathepsin L either,
possibly because the specific inhibitor of the cysteine protease
cathepsin L in the testis is cystatin C (Fritz et al.) (Fig. 6). Since
immunoprecipitation of testis lysates with a 2-MG, and the
resultant blot subsequently stained with an anti-TGF-b 3
antibody, revealed a minor protein band close to the 12.5 kDa
TGF-b 3 band, it was difficult to unequivocally demonstrate that
a 2-MG structurally associated with
TGF-b 3. Therefore, an anti-TGF-b 3
antibody was used instead for
immunoprecipitation using testis
lysates as shown in Fig. 6. a 2-MG
indeed was shown to associate with
this cytokine in normal testis, which
was also induced in testis by 24 hours
post-CdCl2 treatment (Fig. 6),
consistent with data shown in Fig. 2.
Controls using testis lysates incubated
with normal rabbit serum or without
incubation with any antibodies during
immunoprecipitation produced no
detectable band (data not shown). 
Changes in the protein levels and
immunostaining pattern of TJ- and
AJ-associated molecules,
proteases, protease inhibitors and
cytokines in CdCl2-treated rat
testes after SB202190
administration
A recent in vitro study demonstrated
that TGF-b 3 might regulate Sertoli
cell TJ dynamics via the p38 MAP
kinase pathway (Lui et al., 2003a).
Furthermore, the intratesticular
injection of SB202190, a specific p38
MAP kinase inhibitor, delayed the
CdCl2-induced occludin loss at the site
of BTB in vivo (Lui et al., 2003d). In this study, we sought to
expand these earlier studies to investigate if cytokines can also
regulate AJ dynamics via the p38 MAP kinase pathway. When
SB202190 was administrated to the rat testis prior to CdCl2
treatment and testes were collected 16 hours after CdCl2
administration, it was found that SB202190 not only blocked the
CdCl2-induced loss of occludin and ZO-1, but also blocked the
loss of N-cadherin, E-cadherin, b -catenin, nectin-3 and l-afadin
from the seminiferous epithelium (Fig. 7). It also suppressed the
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Fig. 3. Immunohistochemical localization
of ZO-1 in the seminiferous epithelium of
adult rat testes during CdCl2-induced
BTB damage. (A) Low magnification of a
cross section of a rat testis at 0 hours
immunostained with an anti-ZO-1
antibody, and (B) a control section where
normal rabbit serum was substituted for
the primary antibody. (C-H) Micrographs
at high magnifications of rat testes after
CdCl2 treatment (3 mg/kg b.w.i.p.).
Immunoreactive ZO-1 appears as reddish-
brown precipitates localized at the basal
compartment consistent with the site of
the BTB (see arrowheads in A). These
micrographs are typical of the results
from at least 120 cross sections from
three testes of different rats. Scale bar:
(A,B) 200 m m; (C-H) 80 m m; (C inset,
applies to insets in D-G) 20 m m.
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BTB-damage-mediated cathepsin L induction (Fig. 7). Yet
SB202190 pretreatment failed to affect the level of a 2-MG
during CdCl2-induced BTB damage (Fig. 7). The observations
reported herein (Fig. 7) were subsequently confirmed using
immunohistochemistry to locate occludin, ZO-1, N-cadherin
and a 2-MG in the seminiferous epithelium with and without
SB202190 pretreatment during the CdCl2-induced BTB
damage (Fig. 8). For occludin, ZO-1 and N-cadherin, the
immunoreactive belts of staining at the site of the BTB were
weakened after CdCl2 treatment (positive controls) (Fig. 8B,E,H
compared with A,D,G, respectively), yet pretreatment of rat
testes with SB202190, to block the downstream TGF-b 3 action,
effectively blocked the BTB damage-
associated protein loss from the BTB
sites (Fig. 8C,F,I compare with A,D,G
and B,E,H). However, the staining of
a 2-MG in testes pretreated with
SB202190 before CdCl2 administration
(Fig. 8L) did not show any observable
differences when compared with
vehicle pretreatment followed by CdCl2
(Fig. 8L versus Fig. 8K), suggesting
that the changes in a 2-MG during the
BTB damage was not regulated by
TGF-b 3, or if it was, it was not
mediated via the p38 MAP kinase
pathway.
Discussion
Can the use of
immunofluorescence microscopy
and immunoblotting to monitor the
levels of occludin and ZO-1 at the
site of the BTB be a reliable
indicator of BTB integrity?
Cadmium is a major industrial pollutant
and environmental toxicant that can
cause significant damage to many
organs, including the lung, liver, kidney
and testis in humans and rodents (for a review, see Prozialeck,
2000). Its damaging effects to the testis have been known for
decades, including disruption of the Sertoli cell TJ-barrier
function and the vascular system, failure of spermiation, germ
cell loss from the seminiferous epithelium, tissue necrosis and
apoptosis (Aoki and Hoffer, 1978; Gunn and Gould, 1970; Hew
et al., 1993a; Mason et al., 1964; Xu et al., 1996), some of which
can be prevented by zinc (Parizek, 1957). More recent studies
have suggested that its primary site of action in the testis is the
Sertoli cell, perturbing the TJ-barrier function in vitro (Chung and
Cheng, 2001; Janecki et al., 1992) and in vivo (Hew et al., 1993b;
Setchell and Waites, 1970). As such, the injection of CdCl2 in
Fig. 4. Immunofluorescence microscopy to
identify occludin and ZO-1 in the
seminiferous epithelium of rat testes at the
BTB site during CdCl2-induced BTB
damage. (A-O) Immunofluorescence
micrographs of cross sections of normal
rat testes (A-C) and rat testis at 7 hours
(D-F), 12 hours (G-I) and 24 hours (J-O)
after CdCl2 treatment. Occludin appears as
red fluorescence (Cy-3, white arrowheads
in A), ZO-1 as green fluorescence (FITC,
arrowheads in B). (C,F,I,L,O) Merged
images of the corresponding
immunofluorescence micrographs for
occludin and ZO-1, in which co-
localization appears orange (arrowheads in
C). White broken lines in M-O indicate the
approximate location of the basement
membrane of the seminiferous epithelium.
Scale bar: 20 m m.
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vivo to induce BTB damage is regarded as one of the best models
to study TJ dynamics in the testis (for reviews, see Cheng
and Mruk, 2002; Lui et al., 2003b). Yet the techniques used in
earlier studies to monitor BTB integrity are tedious and time
consuming, requiring expensive equipment and the use of
radioisotopes, confocal microscopy, electron microscopy, and
micropuncture techniques (Chung et al., 2001; Eng et al., 1994;
Hew et al., 1993b; Wiebe et al., 2000). By using dual
immunofluorescence microscopy we have shown that both
occludin and ZO-1 are localized at the
same site at the basal compartment of the
seminiferous epithelium, consistent with
their localization at the BTB, forming an
almost superimposable yet continuous
fluorescent ring encircling the entire base
of each tubule. By 20 hours after CdCl2
treatment, a significant reduction in both
ZO-1 and occludin proteins was detected
by immunoblotting, consistent with
results of immunohistochemistry. More
importantly, the dual fluorescent belt-
like structure at the site of BTB was
badly disrupted when visualized by
immunofluorescence miscroscopy. Taken collectively, these
results illustrate unequivocally that the use of both
immunoblotting and fluorescence microscopy techniques
can quantitatively assess the BTB integrity. 
Are the changes in target proteins in the
seminiferous epithelium reported herein secondary
to the vascular damage induced by CdCl2?
It is of interest to note that CdCl2 can also induce vascular
damage (Hew et al., 1993b; Setchell and Waites, 1970),
which was detected in some rats in our experiments at 24
hours after CdCl2 exposure, when red blood cells were
found in the interstitium. Thus, it is possible that some of the
changes seen in Sertoli cells are secondary effects to anoxia.
While such a possibility exists, it is not likely to be the
case for the following reasons. First, a disruption of the
seminiferous epithelial barrier function was detected by both
immunohistochemistry and fluorescence microscopy by 7
hours when red blood cells were not yet detected in the
interstitium, suggesting that the Sertoli cell-based BTB
function was disrupted prior to the damage of the vascular
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Fig. 5. Immunohistochemical localization
of protease inhibitor a 2-MG in the
seminiferous epithelium of rat testes at the
BTB site during CdCl2-induced BTB
damage. (A-D) Immunoreactive a 2-MG in
the seminiferous epithelium after treatment
of rats with CdCl2 (3 mg/kg b.w., i.p.).
Shown are different magnifications of cross
sections of testes at time 0 hours, 20 hours,
24 hours and 96 hours. Immunoreactive a 2-
MG appears as reddish-brown precipitates.
(E) Control in which normal rabbit serum
was substituted for the primary antibody,
illustrating that the staining for a 2-MG
shown in A-D is specific. The smaller
images in A, B and E are higher
magnifications of the representative
micrographs shown on the left panel that
illustrate the cellular localization of a 2-MG
in the seminiferous epithelium. Bars in left
panel of A and E, 200 m m; bars in C, in
middle panel of A and right panel of E, 80
m m; bar in right panel of A, 20 m m. Bars
shown in A are applicable to B, and bar in C
is applicable to D.
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barrier function. This result is also consistent with an
earlier study by Setchell and Waites (Setchell and Waites,
1970) indicating that the BTB function is compromised
by CdCl2 prior to the vascular damage. Obviously, in
order to clarify this, further experiments must be
conducted to assess the kinetics of vascular and BTB
damages following treatments of rats with 0.5-1 versus
3 mg CdCl2/kg b.w., i.p., using more sensitive markers,
such as proteins that specifically constitute these TJs.
Second, when a single dose of 1 mg/kg b.w. of CdCl2 was
used, it failed to induce visible vascular lesions in rat
testes, i.e. blood cells were not detected in the testes of
any of the animals examined (n=4 for each time point),
which is consistent with an earlier report that the
damaging effects of CdCl2 on the vascular barrier in
testes was not visible at 0.5 or 1 mg/kg b.w. (Hew et al.,
1993a). However, we can still detect similar patterns of
induction of a 2-MG and reduction of occludin in all
animals treated with 1 mg/kg b.w. CdCl2 (and visible
damage to the seminiferous epithelial barrier in some rats
at 48 and 72 hours, seen by immunofluorescence microscopy
and immunohistochemistry), consistent with our postulate that
changes in these target proteins take place before any visible
damage to the BTB function. In essence, BTB dynamics are
regulated by the intricate interactions of cytokines, proteases,
protease inhibitors and TJ-integral membrane proteins. Third,
and perhaps the most important of all, the use of SB202190, a
specific inhibitor of p38 MAP kinase, indeed blocked the
CdCl2-induced loss of ZO-1 and occludin from the site of the
BTB, abolishing the disruptive effects of TGB- b 3 on the
Sertoli cell-TJ barrier function as reported earlier (Lui et al.,
2003a; Lui et al., 2003d). This clearly illustrates the
physiological significance of TGF-b 3 in BTB dynamics.
Fig. 6. Studies by co-immunoprecipitation to investigate the
association of the protease inhibitor a 2-MG with TGF-b 3,
cathepsin L, and TJ-associated, AJ-associated and cytoskeletal
proteins during CdCl2-induced BTB damage.
Immunoprecipitation was performed using either anti-a 2-MG
or anti-TGF-b 3 antibody and lysates of testes from rats that
had received CdCl2 (3 mg/kg b.w., i.p.) at 0, 24 and 96 hours
earlier. For positive controls, lysates of testes from rats (~150
m g protein per lane) at 20 hours after CdCl2 treatment without
immunoprecipitation were used since at this time most target
proteins pertinent to our studies were induced (see Fig. 2),
confirming the specificity of the antibodies. Only a set of
representative data is shown, but two other experiments using
different rat testis lysates yielded identical results.
Fig. 7. A study to assess if a blockade of the p38 MAP kinase by
SB202190 can delay the CdCl2-induced target protein losses from
the sites of BTB and AJs in the testis during BTB damage. Normal
rat testes (negative controls) (Ctrl), and testes injected with 1%
DMSO in saline (vol/vol, intratesticular administration) followed by
CdCl2 treatment served as positive controls (CdCl2/vehicle). For test
groups (n=3-5 rats), testes of rats were pre-treated with 8 nmol
SB202190 in 200 m l saline with 1% DMSO (i.e. 5 m M assuming a
volume of 1.6 ml per testis), followed by CdCl2 treatment (3 mg/kg
b.w.i.p.) (CdCl2 + SB202190), and rats were sacrificed 16 hours later.
Lysates were prepared from these samples for immunoblotting with
antibodies against occludin, ZO-1, N-cadherin, E-cadherin, b -
catenin, nectin-3, l-afadin, cathepsin L, a 2-MG, and TGF- b 3.
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Furthermore, this inhibitor also prevented the CdCl2-induced
loss of several AJ proteins, such as N- and E-cadherin, b -
catenin, nectin-3 and afadin from the seminiferous epithelium,
suggesting that AJ dynamics are regulated via the TGF-b 3/p38
MAP kinase pathway. Undoubtedly, changes of target proteins
detected in the testis in particular at ~24 hours onwards could
be somewhat affected by the disruption of the vascular barrier
function. Yet this cannot negate the significance of our finding
that a primary disruption of the Sertoli cell-barrier function can
contribute to a secondary loss of Sertoli-germ cell adhesive
function, because the TGF- b 3/p38 MAP kinase pathway was
shown to be used by the seminiferous epithelium to regulate
both TJ and AJ dynamics. Our findings also illustrate the
shortcoming of this CdCl2 model to study BTB dynamics since
it is not entirely clear how much of the current data stems from
changes in blood vessel barrier function in the testis, unless
CdCl2 targets itself specifically to a TJ-integral membrane
protein at the site of the BTB, which is not found in vascular
endothelial junctions. 
Does the primary disruption of TJs also lead to
secondary loss of cell adhesion function at the site of
AJs? If it does, what is the signaling pathway that
regulates AJ disruption? 
The loss of BTB integrity in the testis by 20-24 hours following
CdCl2 treatment is accompanied by a subsequent loss of germ
cells from the seminiferous epithelium, which became clearly
visible by 24-96 hours. For instance, by 24 hours, ~50% of
the tubules were devoid of elongate/elongating and round
spermatids. Greater than 90% of the tubules examined were
devoid of germ cells by 96 hours. The damaging effect
of CdCl2 on the BTB were irreversible since
immunohistochemistry studies have shown that the BTB
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Fig. 8. Immunohistochemical
localization of occludin, ZO-1, N-
cadherin and a 2-MG in the
seminiferous epithelium of rat
testes with and without
pretreatment with either SB202190
or vehicle (1% DMSO) (via
intratesticular injection) prior to
CdCl2 administration to induce
BTB damage. (A-L) Micrographs
of seminiferous epithelium of
normal rats (A,D,G,J, negative
controls), rats pretreated with
vehicle (1% DMSO) followed by
CdCl2 (B,E,H,K; positive controls),
and rats pretreated with 5 m M
SB202190 followed by CdCl2
(C,F,I,L; test). A-C, D-F, G-I and J-
L show the immunohistochemical
localization of occludin, ZO-1, N-
cadherin and a 2-MG, respectively.
It is noted that after the pre-
treatment of testes with SB202190,
the CdCl2-induced losses of
occludin (C compared with B),
ZO-1 (F compared with E) and N-
cadherin (I compared with H) were
blocked. However, the induction of
a 2-MG expression by CdCl2 was
not affected (L compared with K).
Scale bar in A: 80 m m, applicable
to B-L. 
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remained ‘broken’ by 4 weeks (data not shown), consistent
with earlier reports of the permanent damaging effects of
CdCl2 on BTB function and spermatogenesis (Hew et al.,
1993a; Setchell and Waites, 1970). These results suggest that
either the damaging effect of CdCl2 on Sertoli cells is
permanent or all the spermatogonia are depleted from the
epithelium, or both. This observation is somewhat similar to
the effects of glycerol on the BTB in rats, which also induces
irreversible germ cell loss from the epithelium (for a review,
see Wiebe et al., 1986). Collectively, these data suggest that a
primary loss of BTB function can lead to a secondary loss of
cell adhesion function that induces the loss of germ cells. 
Studies by immunoblotting and immunohistochemistry
have shown that the disappearance of occludin and ZO-1 from
the site of TJs is indeed accompanied by a loss of cadherin/
catenin and afadin/nectin proteins, two putative protein
complexes that constitute the ES in the testis (for reviews, see
Cheng and Mruk, 2002; Lui et al., 2003c; Ozaki-Kuroda
et al., 2002; Vogl et al., 2000), from the site of AJs. This
time frame of losses of AJ integral membrane proteins in
the cadherin/catenin and nectin/afadin protein complexes
coincides with the disappearance of germ cells from the
seminiferous epithelium. It is not likely that the loss of these
four AJ proteins is entirely the consequence of germ cell
disappearance from the epithelium, although recent studies
have shown that Sertoli and germ cells contribute almost
equally to the pool of these proteins (Lee et al., 2003). This
is because the amount of these AJ proteins during CdCl2-
induced BTB damage is 4- to 5-fold less than that in normal
rat testes by 24 hours after CdCl2 treatment, several orders
of magnitude greater than the 50% drop that would be
anticipated (note: assuming cadherins or nectins residing in
Sertoli and germ cells interact with each other as N-
cadherin:N- or E-cadherin and nectin-2:nectin-2/-3 using a
1:1 ratio) if germ cell disappearance from the epithelium
alone accounted for all the losses. Besides, the use of
SB202190 to inhibit p38 MAP kinase activity, downstream of
TGF- b 3, blocked the loss of N- cadherin, E-cadherin, b -
catenin, l-afadin and nectin-3 (but not a 2-macrogloublin),
together with occludin and ZO-1, from the site of ES and/or
BTB. This clearly illustrates that the function of both
cadherin/catenin and afadin/nectin complexes are regulated,
Fig. 9. A schematic drawing that illustrates how protease inhibitors,
such as a 2-MG, may be involved in the regulation of TJ and AJ
dynamics in the seminiferous epithelium. This proposal is based on
the results reported herein and other recent studies (Siu et al.,
2003a; Siu et al., 2003b; Siu and Cheng, 2004; Mruk et al., 2003;
Lui et al., 2003a; Lui et al., 2003b). This diagram also illustrates
the current yet simplified molecular architecture of different TJ and
AJ protein complexes in the testis (for reviews, see Cheng and
Mruk, 2002; Lui et al., 2003b; Lui et al., 2003c). Occludin and ZO-
1/-2/-3 are the major constituent proteins of TJ fibrils found in
Sertoli cells at the BTB site. The cadherin/catenin and nectin/afadin
complexes are the putative AJ protein complexes in the testis. They
are connected to the actin cytoskeleton network, partly by a -
catenin. When TJs and AJs are ‘closed’, the junction-associated multiprotein complexes of two apposed cells interact with each other, whereas
the level and/or activity of cytokines and proteases apparently are kept low by a 2-MG. However, when TJ and AJ disassemble (or ‘open’), such
as when treated with CdCl2, junction functionality is perturbed. This may be mediated by cytokines, such as TGF- b 3 and TNF a that bind to
their receptors and lead to the rapid turnover (possibly undergoing proteolysis) of junction components (represented by broken lines) via the
p38 MAP kinase signal pathway. Proteases activities may also be induced, facilitating junction dissociation. At this time, the amount of the
protease inhibitor a 2-MG in the seminiferous tubules increases, binding to the excessive cytokines to limit their action, or inhibiting proteases
to protect the integrity of the BTB. As such, protease inhibitors may act as ‘rescuers’ during junction remodeling in the testis, regulating the
homeostasis of proteins that constitute both TJs and AJs.
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at least in part, by TGF- b 3 via the p38 MAP kinase signaling
pathway during AJ disruption. The experiments using
SB202190 to prevent the loss of TJ and AJ integral membrane
proteins from the seminiferous epithelium have demonstrated
unequivocally for the first time that the TGF- b 3/p38 MAP
kinase pathway is being used to regulate both TJ and AJ
dynamics in the testis in vivo. 
Moreover, AJ disruption mediated by CdCl2 is likely to
involve p120ctn and c-Src, two putative signaling and
regulatory AJ peripheral proteins (for reviews, see Anastasiadis
and Reynolds, 2000; Cheng and Mruk, 2002; Thomas and
Brugge, 1997). Their inductions were detected at 12-24 hours
and 7-16 hours after CdCl2 treatment, respectively. This
coincides with the time frame of germ cell loss from the
epithelium, suggesting that the AJ signaling network has been
activated to elicit AJ disruption. The activation of c-Src, an
upstream activator of p120ctn, may lead to an induction, and
possibly the phosphorylation, of p120ctn (for a review, see
Daniel and Reynolds, 1997). This in turn causes the loss of cell
adhesion function in the cadherin/catenin complex, as recent
findings have suggested that p120ctn is an inhibitory regulator
of this complex (for a review, see Anastasiadis and Reynolds,
2000). In cells with over-expression of p120ctn, or with normal
expression of p120ctn but having mutations at selected
phosphorylation sites, or with hyperphosphorylation of
p120ctn, the cadherin-mediated adhesion is defective; but the
inclusion of Ser/Thr protein kinase inhibitors can restore cell
adhesive function (Aono et al., 1999; Daniel and Reynolds,
1997). 
In contrast, the regulatory signaling molecules that trigger
the loss of adhesion function in the nectin/afadin complex are
not entirely known. Nonetheless, the nectin/afadin complex
was shown to tightly associate with the cadherin/catenin
complex and the phosphorylation of nectin-2 was detected in
response to nectin-afadin-mediated cell-cell adhesion (Kikyo
et al., 2000). But it is not known whether c-Src, a protein
tyrosine kinase, can regulate the phosphorylation status of
nectins. It is also possible that the disruption of the
nectin/afadin-based AJs can be a direct consequence of the TJ
disruption, since nectin is implicated in TJ organization, and
afadin is physically linked to ZO-1, forming a 1:1
stoichiometric association (Fukuhara et al., 2002a; Fukuhara et
al., 2002b). As such, a disruption of TJs can perturb the
underlying nectin/afadin-based AJ structural function. 
What roles do proteases and protease inhibitors have in
junction dynamics in vivo?
Sertoli and germ cells are known to produce a number of
proteases and protease inhibitors, and the interplay of these
molecules regulates different testicular functions pertinent
to spermatogenesis (for a review, see Fritz et al., 1993). For
example, proteases produced by Sertoli cells remove
apoptotic germ cells and other residual organelles during the
epithelial cycle, possibly via the ubiquitin and lysosome
pathways (for reviews, see de Kretser and Kerr, 1988;
Russell, 1980). Yet their role(s), if any, in junction dynamics
is not known. It is conceivable that the coordinate interactions
of proteases and protease inhibitors are crucial not only to the
‘opening’ or ‘closing’ of junctions (Fig. 9) but also in
removing unwanted junctional complex components. Indeed,
it was shown that the presence of chloroquine, a protease
inhibitor, in Sertoli cell cultures could facilitate the assembly
and maintenance of TJ barrier function, making the TJ barrier
‘tighter’ than in control cultures (Okanlawon and Dym,
1996). Also, the assembly of the Sertoli cell-TJ barrier (Wong
et al., 2000) or TJ barrier reassembly following its disruption
by CdCl2 treatment (Chung and Cheng, 2001) in vitro
was associated with an induction of a 2-macroglobulin,
implicating its significance in TJ dynamics. Furthermore, co-
cultures of germ cells with a Sertoli cell epithelium in vitro,
which mimics AJ reassembly events in vivo, induced protease
activities in these cells (Mruk et al., 1997), while an
intriguing expression pattern between proteases and protease
inhibitors was shown during Sertoli-germ cell AJ assembly
(Mruk et al., 1997). Addition of a 2-macroglobulin to Sertoli-
germ cell cocultures can also facilitate the assembly of
Sertoli-germ cell AJs as shown by an in vitro cell adhesion
assay (Mruk et al., 2003). 
As shown in the present study, the loss of the BTB integrity
and cell adhesion function in the epithelium after CdCl2
treatment was associated with an increase in cathepsin L. This
protease has been implicated in junction restructuring events,
such as facilitating spermiation (Chung et al., 1998; Penttila et
al., 1995; Wright et al., 1995), suggesting that its induction
may be necessary for junction cleavage. Unlike a 2-
macroglobulin, cathepsin L is regulated by TGF- b 3 via the p38
MAP kinase pathway since the presence of SB202190 can
block the CdCl2-induced cathepsin L production in the testis.
Beside cathepsin L, MMP-2 was also induced transiently
during the CdCl2-induced BTB damage. Collectively, these
data illustrate the significance of proteases in the junction
dynamics of the testis. 
a 2-Macroglobulin was initially isolated from Sertoli cell-
conditioned media in the 1990s and was subsequently shown
to be a product of Sertoli, but not germ cells. Its expression in
the seminiferous epithelium behind the BTB is regulated quite
differently from that produced by hepatocytes in the liver
(Cheng et al., 1990; Stahler et al., 1991). Although a 2-
macroglobulin is an acute-phase protein in the liver, in the
testis it responds neither to glucocorticoids, cytokines, nor
experimental induced inflammation (Braghiroli et al., 1998;
Stahler et al., 1991), suggesting a specific role in the testis. The
induction of a 2-macroglobulin during CdCl2-induced BTB
damage thus prompted us to investigate whether this protease
inhibitor associates with proteins of the junctional complexes.
While a 2-macroglobulin does not associate with either
occludin, E-cadherin, N-cadherin, g -catenin, or cathespin L (a
cysteine protease), it does associate with the nectin-afadin
protein complex and cytoskeletal proteins actin and vimentin,
illustrating its possible function in AJ dynamics via the
nectin/afadin complex. Equally important, a 2-macroglobulin
was shown to associate with TGF- b 3 structurally. a 2-
Macroglobulin is found in the extracellular matrix (ECM) in
other epithelia and is known to bind TGF- b , TNF-a and
interleukins (for a review, see Feige et al., 1996). Both TGF-
b 3 (Lui et al., 2003a; Lui et al., 2003d) and TNF- a (Siu et al.,
2003a) have recently been shown to be crucial regulators
of TJ dynamics. Therefore, the demonstration of structural
interactions between a 2-macroglobulin and cytokines, such
as TGF- b 3 reported herein, undoubtedly illustrates the
physiological and clinical significance of this protease inhibitor
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in TJ dynamics, i.e. maintaining the homeostasis of cytokines.
Taken collectively, these findings suggest that a 2-
macroglobulin apparently plays a crucial role in regulating
both TJ and AJ dynamics via its interaction with TGF- b 3. It
maintains the pool of TGF- b 3 that regulates both TJ-associated
proteins and AJ multi-protein complexes in the testis, such as
the ES. 
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